CTSO

Cytosorbents Corporation (CTSO) is a pioneering company at the forefront of critical care immunotherapy, focusing on cutting-edge blood purification technologies designed to enhance patient outcomes in severe medical conditions. Leveraging its proprietary adsorbent and porous polymer innovations, Cytosorbents effectively targets the removal of harmful substances from the bloodstream, addressing critical unmet needs in the healthcare sector. Based in Monmouth Junction, New Jersey, the company is strategically positioned to transform treatment protocols globally, continually advancing the standards of patient health, safety, and recovery.